Bayesian variable selection and survival modeling: assessing the Most important comorbidities that impact lung and colorectal cancer survival in Spain
Open Access
- 3 April 2022
- journal article
- research article
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 22 (1) , 1-14
Abstract
Cancer survival represents one of the main indicators of interest in cancer epidemiology. However, the survival of cancer patients can be affected by several factors, such as comorbidities, that may interact with the cancer biology. Moreover, it is interesting to understand how different cancer sites and tumour stages are affected by different comorbidities. Identifying the comorbidities that affect cancer survival is thus of interest as it can be used to identify factors driving the survival of cancer patients. This information can also be used to identify vulnerable groups of patients with comorbidities that may lead to worst prognosis of cancer. We address these questions and propose a principled selection and evaluation of the effect of comorbidities on the overall survival of cancer patients. In the first step, we apply a Bayesian variable selection method that can be used to identify the comorbidities that predict overall survival. In the second step, we build a general Bayesian survival model that accounts for time-varying effects. In the third step, we derive several posterior predictive measures to quantify the effect of individual comorbidities on the population overall survival. We present applications to data on lung and colorectal cancers from two Spanish population-based cancer registries. The proposed methodology is implemented with a combination of the R-packages and . We provide the code for reproducibility at https://github.com/migariane/BayesVarImpComorbiCancer.Keywords
All Related Versions
Funding Information
- Fondo Nacional de Desarrollo Cient?fico y Tecnol?gico (11190018)
- Instituto de Salud Carlos III
- ISCIII (CP17/00206)
This publication has 31 references indexed in Scilit:
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countriesThe Lancet, 2018
- Methods and Tools for Bayesian Variable Selection and Model Averaging in Normal Linear RegressionInternational Statistical Review, 2018
- Comorbid conditions delay diagnosis of colorectal cancer: a cohort study using electronic primary care recordsBritish Journal of Cancer, 2017
- Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbiditiesPLOS ONE, 2017
- Emerging Biological Principles of MetastasisCell, 2017
- The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubtStatistics in Medicine, 2011
- Survival attributable to an exposureStatistics in Medicine, 2009
- Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distributionStatistics in Medicine, 2007
- Posterior model probabilities via path‐based pairwise priorsStatistica Neerlandica, 2005
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987